Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	carbon-sulfur lyase activity	KYAT1 CENPVL2 CENPVL3 CENPVL1	6.54e-06	16	159	4	GO:0016846
GeneOntologyMolecularFunction	histone binding	SMARCA5 TSPY4 TSPY3 TSPY2 TSPY9 TSPYL6 TSPY8 TSPY1 SBNO2 SBNO1 TSPY10	9.35e-06	265	159	11	GO:0042393
GeneOntologyMolecularFunction	lipid transporter activity	ATP8B3 SLCO4A1 ABCA7 PLEKHA8P1 SLC27A1 STARD3 SCP2 ANO7 SLC27A5	2.82e-05	196	159	9	GO:0005319
GeneOntologyMolecularFunction	acetylgalactosaminyltransferase activity	GALNTL6 GALNT10 CHSY3 B4GALNT3	1.67e-04	35	159	4	GO:0008376
GeneOntologyMolecularFunction	chromatin binding	SMARCA5 DDX12P TSPY4 SREBF2 TSPY3 SHMT2 TSPY2 TSPY9 TSPYL6 TSPY8 TSPY1 ZNF692 SBNO2 SBNO1 TSPY10 UTY	2.81e-04	739	159	16	GO:0003682
GeneOntologyMolecularFunction	phospholipid transporter activity	ATP8B3 ABCA7 PLEKHA8P1 SCP2 ANO7	3.11e-04	74	159	5	GO:0005548
GeneOntologyBiologicalProcess	gonadal mesoderm development	TSPY4 TSPY3 TSPY2 TSPY9 TSPY8 TSPY1 TSPY10	4.39e-14	9	156	7	GO:0007506
GeneOntologyBiologicalProcess	nucleosome assembly	SMARCA5 TSPY4 TSPY3 TSPY2 TSPY9 TSPYL6 TSPY8 TSPY1 TSPY10	3.78e-07	122	156	9	GO:0006334
GeneOntologyBiologicalProcess	nucleosome organization	SMARCA5 TSPY4 TSPY3 TSPY2 TSPY9 TSPYL6 TSPY8 TSPY1 TSPY10	1.36e-06	142	156	9	GO:0034728
GeneOntologyBiologicalProcess	mesoderm development	TSPY4 TSPY3 TSPY2 TSPY9 TSPY8 TSPY1 EYA2 BMP4 TSPY10	3.13e-06	157	156	9	GO:0007498
GeneOntologyBiologicalProcess	reproductive structure development	TSPY4 TSPY3 TSPY2 TSPY9 BCL2 BCL2L1 TSPY8 TSPY1 BMP4 GDF7 SLC22A5 EIF2B4 TSPY10	7.24e-06	383	156	13	GO:0048608
GeneOntologyBiologicalProcess	reproductive system development	TSPY4 TSPY3 TSPY2 TSPY9 BCL2 BCL2L1 TSPY8 TSPY1 BMP4 GDF7 SLC22A5 EIF2B4 TSPY10	8.32e-06	388	156	13	GO:0061458
GeneOntologyBiologicalProcess	gonad development	TSPY4 TSPY3 TSPY2 TSPY9 BCL2 BCL2L1 TSPY8 TSPY1 BMP4 EIF2B4 TSPY10	1.43e-05	292	156	11	GO:0008406
GeneOntologyBiologicalProcess	development of primary sexual characteristics	TSPY4 TSPY3 TSPY2 TSPY9 BCL2 BCL2L1 TSPY8 TSPY1 BMP4 EIF2B4 TSPY10	1.68e-05	297	156	11	GO:0045137
GeneOntologyBiologicalProcess	protein-DNA complex assembly	SMARCA5 TSPY4 TSPY3 TSPY2 TSPY9 TSPYL6 TSPY8 TSPY1 CENPP TSPY10	2.06e-05	249	156	10	GO:0065004
GeneOntologyBiologicalProcess	sex differentiation	TSPY4 TSPY3 TSPY2 TSPY9 BCL2 BCL2L1 TSPY8 TSPY1 BMP4 EIF2B4 TSPY10	7.86e-05	352	156	11	GO:0007548
GeneOntologyBiologicalProcess	mesenchyme development	TSPY4 TSPY3 TSPY2 TSPY9 BCL2 TSPY8 TSPY1 BMP4 DCHS1 TSPY10 TNXB	1.28e-04	372	156	11	GO:0060485
HumanPheno	Adrenal overactivity	CDH23 OCRL SLC12A3 KCNJ11 KCNJ16 CACNA1H	6.17e-06	55	44	6	HP:0002717
HumanPheno	Abnormal adrenal morphology	CDH23 OCRL BMP4 SLC12A3 KCNJ11 KCNJ16 CACNA1H TNXB	2.64e-05	145	44	8	HP:0011732
HumanPheno	Abnormal endocrine morphology	CDH23 OCRL BMP4 SLC12A3 KCNJ11 KCNJ16 CACNA1H TNXB	2.64e-05	145	44	8	HP:0031071
HumanPheno	Adrenocortical abnormality	CDH23 OCRL SLC12A3 KCNJ11 KCNJ16 CACNA1H	4.38e-05	77	44	6	HP:0000849
HumanPheno	Abnormal periodontium morphology	USP9X C1R	7.29e-05	2	44	2	HP:0410026
Domain	NAP_family	TSPY4 TSPY2 TSPYL6 TSPY8 TSPY10	1.91e-07	17	152	5	IPR002164
Domain	NAP	TSPY4 TSPY2 TSPYL6 TSPY8 TSPY10	1.91e-07	17	152	5	PF00956
Domain	EGF_1	STAB2 ZAN NTN3 SNED1 CNTNAP5 NRXN1 MEGF8 NTN5 C1R TNXB NPNT	7.87e-06	255	152	11	PS00022
Domain	EGF_2	STAB2 ZAN NTN3 SNED1 CNTNAP5 NRXN1 MEGF8 NTN5 C1R TNXB NPNT	1.13e-05	265	152	11	PS01186
Domain	-	ATP8B3 ACAD10 EYA2 CMAS ATP13A3 CTDSPL	1.34e-05	64	152	6	3.40.50.1000
Domain	EGF	STAB2 ZAN SNED1 CNTNAP5 FCGBP NRXN1 MEGF8 C1R TNXB NPNT	2.32e-05	235	152	10	SM00181
Domain	EGF-like_dom	STAB2 ZAN SNED1 CNTNAP5 FCGBP NRXN1 MEGF8 C1R TNXB NPNT	3.79e-05	249	152	10	IPR000742
Domain	HAD-like_dom	ATP8B3 ACAD10 EYA2 CMAS ATP13A3 CTDSPL	4.48e-05	79	152	6	IPR023214
Domain	Bcl2/BclX	BCL2 BCL2L1	6.58e-05	2	152	2	IPR004725
Domain	SNO	SBNO2 SBNO1	6.58e-05	2	152	2	IPR026741
Domain	SBNO_Helicase_C_dom	SBNO2 SBNO1	6.58e-05	2	152	2	IPR026937
Domain	Helicase_C_4	SBNO2 SBNO1	6.58e-05	2	152	2	PF13871
Domain	EGF_LAM_2	STAB2 NTN3 MEGF8 NTN5	9.80e-05	30	152	4	PS50027
Domain	EGF_LAM_1	STAB2 NTN3 MEGF8 NTN5	9.80e-05	30	152	4	PS01248
Domain	EGF_3	STAB2 ZAN SNED1 CNTNAP5 NRXN1 MEGF8 C1R TNXB NPNT	1.34e-04	235	152	9	PS50026
Domain	EGF_Lam	STAB2 NTN3 MEGF8 NTN5	1.81e-04	35	152	4	SM00180
Domain	TILa_dom	ZAN FCGBP	1.96e-04	3	152	2	IPR025615
Domain	BH4	BCL2 BCL2L1	1.96e-04	3	152	2	PF02180
Domain	TILa	ZAN FCGBP	1.96e-04	3	152	2	PF12714
Domain	Bcl2_BH4_motif_CS	BCL2 BCL2L1	1.96e-04	3	152	2	IPR020731
Domain	BH4	BCL2 BCL2L1	1.96e-04	3	152	2	SM00265
Domain	Laminin_EGF	STAB2 NTN3 MEGF8 NTN5	2.51e-04	38	152	4	IPR002049
Domain	EGF-like_CS	STAB2 ZAN NTN3 SNED1 NRXN1 MEGF8 C1R TNXB NPNT	2.92e-04	261	152	9	IPR013032
Domain	-	GALNTL6 GALNT10 CMAS CHSY3 B4GALNT3	5.21e-04	81	152	5	3.90.550.10
Domain	Bcl2_BH4	BCL2 BCL2L1	6.47e-04	5	152	2	IPR003093
Domain	BH4_2	BCL2 BCL2L1	6.47e-04	5	152	2	PS50063
Domain	BH4_1	BCL2 BCL2L1	6.47e-04	5	152	2	PS01260
Domain	Nucleotide-diphossugar_trans	GALNTL6 GALNT10 CMAS CHSY3 B4GALNT3	7.61e-04	88	152	5	IPR029044
Domain	CUB_dom	LDLRAD2 ADAMTS13 MEGF8 C1R	1.19e-03	57	152	4	IPR000859
Domain	ZINC_PROTEASE	LVRN ADAMTS13 MMP25 ERAP2 ECEL1	1.24e-03	98	152	5	PS00142
Domain	ASX_HYDROXYL	SNED1 NRXN1 MEGF8 C1R NPNT	1.35e-03	100	152	5	PS00010
Domain	Gal_Oxase/kelch_b-propeller	LCMT2 MEGF8 KBTBD11 KLHL8	1.36e-03	59	152	4	IPR011043
Domain	RICIN	GALNTL6 GALNT10 PLA2R1	1.49e-03	28	152	3	SM00458
Domain	RICIN_B_LECTIN	GALNTL6 GALNT10 PLA2R1	1.49e-03	28	152	3	PS50231
Domain	EGF-type_Asp/Asn_hydroxyl_site	SNED1 NRXN1 MEGF8 C1R NPNT	1.75e-03	106	152	5	IPR000152
Domain	Growth_fac_rcpt_	STAB2 NTN3 MEGF8 KAZALD1 TNXB NPNT	1.76e-03	156	152	6	IPR009030
Domain	ERAP1-like_C_dom	LVRN ERAP2	1.78e-03	8	152	2	IPR024571
Domain	Chond_GalNAc	CHSY3 B4GALNT3	1.78e-03	8	152	2	IPR008428
Domain	CHGN	CHSY3 B4GALNT3	1.78e-03	8	152	2	PF05679
Domain	ERAP1_C	LVRN ERAP2	1.78e-03	8	152	2	PF11838
Domain	Bcl2_BH2_motif_CS	BCL2 BCL2L1	1.78e-03	8	152	2	IPR020726
Domain	Bcl2_BH3_motif_CS	BCL2 BCL2L1	1.78e-03	8	152	2	IPR020728
Domain	Bcl2_BH1_motif_CS	BCL2 BCL2L1	1.78e-03	8	152	2	IPR020717
Domain	Ricin_B_lectin	GALNTL6 GALNT10 PLA2R1	1.83e-03	30	152	3	IPR000772
Domain	-	SHMT2 KYAT1 ACCSL	2.86e-03	35	152	3	3.90.1150.10
Domain	Laminin_EGF	NTN3 MEGF8 NTN5	2.86e-03	35	152	3	PF00053
Domain	PyrdxlP-dep_Trfase_major_sub2	SHMT2 KYAT1 ACCSL	3.10e-03	36	152	3	IPR015422
Domain	EGF_CA	STAB2 SNED1 MEGF8 C1R NPNT	3.23e-03	122	152	5	SM00179
Domain	Fol_N	SNED1 FCGBP	3.45e-03	11	152	2	IPR003645
Domain	BH1	BCL2 BCL2L1	3.45e-03	11	152	2	PS01080
Domain	Blc2_fam	BCL2 BCL2L1	3.45e-03	11	152	2	IPR026298
Domain	FOLN	SNED1 FCGBP	3.45e-03	11	152	2	SM00274
Domain	EGF-like_Ca-bd_dom	STAB2 SNED1 MEGF8 C1R NPNT	3.46e-03	124	152	5	IPR001881
Domain	EGF	STAB2 ZAN SNED1 NRXN1 TNXB	3.71e-03	126	152	5	PF00008
Domain	-	SHMT2 KYAT1 ACCSL	3.90e-03	39	152	3	3.40.640.10
Domain	EGF_dom	STAB2 MEGF8	4.12e-03	12	152	2	IPR024731
Domain	Bcl-2	BCL2 BCL2L1	4.12e-03	12	152	2	PF00452
Domain	C8	ZAN FCGBP	4.12e-03	12	152	2	PF08742
Domain	EGF_3	STAB2 MEGF8	4.12e-03	12	152	2	PF12947
Domain	TIL	ZAN FCGBP	4.12e-03	12	152	2	PF01826
Domain	Peptidase_M1	LVRN ERAP2	4.12e-03	12	152	2	IPR001930
Domain	PyrdxlP-dep_Trfase	SHMT2 KYAT1 ACCSL	4.49e-03	41	152	3	IPR015424
Domain	PyrdxlP-dep_Trfase_major_sub1	SHMT2 KYAT1 ACCSL	4.49e-03	41	152	3	IPR015421
Domain	Peptidase_M1_N	LVRN ERAP2	4.84e-03	13	152	2	IPR014782
Domain	Unchr_dom_Cys-rich	ZAN FCGBP	4.84e-03	13	152	2	IPR014853
Domain	Peptidase_M1	LVRN ERAP2	4.84e-03	13	152	2	PF01433
Domain	C8	ZAN FCGBP	4.84e-03	13	152	2	SM00832
Domain	BCL2_FAMILY	BCL2 BCL2L1	4.84e-03	13	152	2	PS50062
Domain	Bcl2-like	BCL2 BCL2L1	4.84e-03	13	152	2	IPR002475
Domain	BH2	BCL2 BCL2L1	4.84e-03	13	152	2	PS01258
Domain	TIL_dom	ZAN FCGBP	5.62e-03	14	152	2	IPR002919
Domain	-	LCMT2 MEGF8 KBTBD11	6.99e-03	48	152	3	2.120.10.80
Domain	VWF_type-D	ZAN FCGBP	7.33e-03	16	152	2	IPR001846
Domain	MAM_1	ZAN NPNT	7.33e-03	16	152	2	PS00740
Domain	VWFD	ZAN FCGBP	7.33e-03	16	152	2	PS51233
Domain	IRK	KCNJ11 KCNJ16	7.33e-03	16	152	2	PF01007
Domain	VWD	ZAN FCGBP	7.33e-03	16	152	2	SM00216
Domain	K_chnl_inward-rec_Kir_cyto	KCNJ11 KCNJ16	7.33e-03	16	152	2	IPR013518
Domain	-	KCNJ11 KCNJ16	7.33e-03	16	152	2	2.60.40.1400
Domain	K_chnl_inward-rec_Kir	KCNJ11 KCNJ16	7.33e-03	16	152	2	IPR016449
Domain	VWD	ZAN FCGBP	7.33e-03	16	152	2	PF00094
Pubmed	Molecular interactions of Bcl-2 and Bcl-xL with mortalin: identification and functional characterization.	BCL2 BCL2L1 HSPA9	1.03e-07	3	164	3	24050266
Pubmed	Improving GENCODE reference gene annotation using a high-stringency proteogenomics workflow.	CENPVL2 CENPVL3 CENPVL1	2.04e-06	6	164	3	27250503
Pubmed	A dual-activity topoisomerase complex regulates mRNA translation and turnover.	LONRF1 OBSCN SLCO4A1 ABCA7 KIAA2013 SBNO2 SLC52A3 BMP4 MEGF8 KCNJ11 KBTBD11 HELZ2 MAP3K11 CACNA1H KAZALD1 PLK3 TOP3A ARAP1	5.27e-06	1105	164	18	35748872
Pubmed	Phospho-Bcl-x(L)(Ser62) plays a key role at DNA damage-induced G(2) checkpoint.	BCL2L1 AURKA PLK3	2.20e-05	12	164	3	22617334
Pubmed	HIV-specific CD8+ T cells exhibit markedly reduced levels of Bcl-2 and Bcl-xL.	BCL2 BCL2L1	2.21e-05	2	164	2	15034060
Pubmed	bcl-XL is the major bcl-x mRNA form expressed during murine development and its product localizes to mitochondria.	BCL2 BCL2L1	2.21e-05	2	164	2	7607090
Pubmed	A novel inhibitory mechanism of mitochondrion-dependent apoptosis by a herpesviral protein.	BCL2 BCL2L1	2.21e-05	2	164	2	18069888
Pubmed	siRNA-mediated Bcl-2 and Bcl-xl gene silencing sensitizes human hepatoblastoma cells to chemotherapeutic drugs.	BCL2 BCL2L1	2.21e-05	2	164	2	17439414
Pubmed	Inhibition of apoptosis in human breast cancer cells: role in tumor progression to the metastatic state.	BCL2 BCL2L1	2.21e-05	2	164	2	12209955
Pubmed	Glucose metabolism is required for oxidized LDL-induced macrophage survival: role of PI3K and Bcl-2 family proteins.	BCL2 BCL2L1	2.21e-05	2	164	2	19667115
Pubmed	Development of a human neuronal cell model for human immunodeficiency virus (HIV)-infected macrophage-induced neurotoxicity: apoptosis induced by HIV type 1 primary isolates and evidence for involvement of the Bcl-2/Bcl-xL-sensitive intrinsic apoptosis pathway.	BCL2 BCL2L1	2.21e-05	2	164	2	12186923
Pubmed	SorCS1-mediated sorting in dendrites maintains neurexin axonal surface polarization required for synaptic function.	SORCS1 NRXN1	2.21e-05	2	164	2	31658245
Pubmed	Proteomic analysis for the identification of serum diagnostic markers for joint hypermobility syndrome.	VTN C1R	2.21e-05	2	164	2	26709396
Pubmed	The Ewing Family of Tumors Relies on BCL-2 and BCL-XL to Escape PARP Inhibitor Toxicity.	BCL2 BCL2L1	2.21e-05	2	164	2	30348635
Pubmed	Variable BCL2/BCL2L1 ratio in multiple myeloma with t(11;14).	BCL2 BCL2L1	2.21e-05	2	164	2	30429160
Pubmed	An Exceptional Gene: Evolution of the TSPY Gene Family in Humans and Other Great Apes.	TSPY9 TSPY1	2.21e-05	2	164	2	24710137
Pubmed	Structure and function of TSPY, the Y-chromosome gene coding for the "testis-specific protein".	TSPY9 TSPY1	2.21e-05	2	164	2	9678360
Pubmed	(-)-Gossypol acts directly on the mitochondria to overcome Bcl-2- and Bcl-X(L)-mediated apoptosis resistance.	BCL2 BCL2L1	2.21e-05	2	164	2	15657350
Pubmed	TSPY-related sequences represent a microheterogeneous gene family organized as constitutive elements in DYZ5 tandem repeat units on the human Y chromosome.	TSPY9 TSPY1	2.21e-05	2	164	2	8244388
Pubmed	Distinct roles of Bcl-2 and Bcl-Xl in the apoptosis of human bone marrow mesenchymal stem cells during differentiation.	BCL2 BCL2L1	2.21e-05	2	164	2	21589877
Pubmed	bcl-x is expressed in embryonic and postnatal neural tissues and functions to prevent neuronal cell death.	BCL2 BCL2L1	2.21e-05	2	164	2	7753802
Pubmed	Bcl-xL phosphorylation at Ser49 by polo kinase 3 during cell cycle progression and checkpoints.	BCL2L1 PLK3	2.21e-05	2	164	2	21840391
Pubmed	Study of Strawberry Notch homolog 1 and 2 expression in human glioblastoma.	SBNO2 SBNO1	2.21e-05	2	164	2	36695974
Pubmed	Characterization of the signal that directs Bcl-x(L), but not Bcl-2, to the mitochondrial outer membrane.	BCL2 BCL2L1	2.21e-05	2	164	2	12515824
Pubmed	Induction of apoptosis and antitumor effects of a small molecule inhibitor of Bcl-2 and Bcl-xl, gossypol acetate, in multiple myeloma in vitro and in vivo.	BCL2 BCL2L1	2.21e-05	2	164	2	23708869
Pubmed	Autophagy is activated, but is not required for the G0 function of BCL-2 or BCL-xL.	BCL2 BCL2L1	2.21e-05	2	164	2	18758240
Pubmed	Suppression of endoplasmic reticulum stress-induced caspase activation and cell death by the overexpression of Bcl-xL or Bcl-2.	BCL2 BCL2L1	2.21e-05	2	164	2	17301078
Pubmed	Cleavage of anti-apoptotic Bcl-2 family members after TCR stimulation contributes to the decision between T cell activation and apoptosis.	BCL2 BCL2L1	2.21e-05	2	164	2	23203923
Pubmed	Regulation of mammalian target of rapamycin complex 1 by Bcl-2 and Bcl-XL proteins.	BCL2 BCL2L1	2.21e-05	2	164	2	23960074
Pubmed	BCL(X)L and BCL2 increase mitochondrial dynamics in breast cancer cell: Evidence from functional and genetic studies.	BCL2 BCL2L1	2.21e-05	2	164	2	34214511
Pubmed	Mitochondrially targeted Bcl-2 and Bcl-X(L) chimeras elicit different apoptotic responses.	BCL2 BCL2L1	2.21e-05	2	164	2	18182854
Pubmed	The spliced variant of hepatitis B virus protein, HBSP, interacts with Bcl-2/Bcl-xl in vitro and induces apoptosis in HepG2 cells.	BCL2 BCL2L1	2.21e-05	2	164	2	18543286
Pubmed	Battle of the sexes: contrasting roles of testis-specific protein Y-encoded (TSPY) and TSPX in human oncogenesis.	TSPY9 TSPY1	2.21e-05	2	164	2	29974883
Pubmed	Aurora Kinase A and Bcl-xL Inhibition Suppresses Metastasis in Triple-Negative Breast Cancer.	BCL2L1 AURKA	2.21e-05	2	164	2	36077449
Pubmed	BCL-xL inhibition potentiates cancer therapies by redirecting the outcome of p53 activation from senescence to apoptosis.	BCL2L1 AURKA	2.21e-05	2	164	2	36543138
Pubmed	Expression of Bcl-2 and Bcl-xL in cutaneous and bone marrow lesions of mastocytosis.	BCL2 BCL2L1	2.21e-05	2	164	2	12937123
Pubmed	BCL-x(L) and BCL2 delay Myc-induced cell cycle entry through elevation of p27 and inhibition of G1 cyclin-dependent kinases.	BCL2 BCL2L1	2.21e-05	2	164	2	12420213
Pubmed	Regulation of the lifespan in dendritic cell subsets.	BCL2 BCL2L1	2.21e-05	2	164	2	17267035
Pubmed	APG-1252-12A induces mitochondria-dependent apoptosis through inhibiting the antiapoptotic proteins Bcl-2/Bcl-xl in HL-60 cells.	BCL2 BCL2L1	2.21e-05	2	164	2	28586007
Pubmed	BCL-2 and BCL-XL restrict lineage choice during hematopoietic differentiation.	BCL2 BCL2L1	2.21e-05	2	164	2	12721288
Pubmed	Hepatitis B virus X protein targets Bcl-2 proteins to increase intracellular calcium, required for virus replication and cell death induction.	BCL2 BCL2L1	2.21e-05	2	164	2	23091012
Pubmed	Antiapoptotic proteins Bcl-2 and Bcl-XL inhibit Clostridium difficile toxin A-induced cell death in human epithelial cells.	BCL2 BCL2L1	2.21e-05	2	164	2	19797069
Pubmed	TSPY, the candidate gonadoblastoma gene on the human Y chromosome, has a widely expressed homologue on the X - implications for Y chromosome evolution.	TSPY9 TSPY1	2.21e-05	2	164	2	15241014
Pubmed	BCL2 and BCLxL are key determinants of resistance to antitubulin chemotherapeutics in melanoma cells.	BCL2 BCL2L1	2.21e-05	2	164	2	23802633
Pubmed	Bcl-XL and Bcl-2 expression in bilharzial squamous cell carcinoma of the urinary bladder: which protein is prognostic?	BCL2 BCL2L1	2.21e-05	2	164	2	18342927
Pubmed	Evaluation of cytotoxic effects induced by bcl-2 and bcl-xL antisense-oligodeoxynucleotides in normal urothelium and transitional cell carcinoma.	BCL2 BCL2L1	2.21e-05	2	164	2	19020723
Pubmed	Human plasma N-glycoproteome analysis by immunoaffinity subtraction, hydrazide chemistry, and mass spectrometry.	VTN ADAMTS13 LCAT FCGBP MEGF8 C1R TNXB PLXNB1	3.23e-05	257	164	8	16335952
Pubmed	Resistance to chemotherapy-induced apoptosis via decreased caspase-3 activity and overexpression of antiapoptotic proteins in ovarian cancer.	BCL2 BCL2L1	6.61e-05	3	164	2	15156398
Pubmed	Evasion of cell death: A contributory factor in prostate cancer development and treatment resistance.	BCL2 BCL2L1	6.61e-05	3	164	2	34343635
Pubmed	Mechanism of Bcl-2 and Bcl-X(L) inhibition of NLRP1 inflammasome: loop domain-dependent suppression of ATP binding and oligomerization.	BCL2 BCL2L1	6.61e-05	3	164	2	19223583
Pubmed	Regulation of Bax mitochondrial localization by Bcl-2 and Bcl-x(L): keep your friends close but your enemies closer.	BCL2 BCL2L1	6.61e-05	3	164	2	23064052
Pubmed	Regulation of bcl-2, bcl-XL and bax in the control of apoptosis by hematopoietic cytokines and dexamethasone.	BCL2 BCL2L1	6.61e-05	3	164	2	7669718
Pubmed	The downregulation of Mcl-1 via USP9X inhibition sensitizes solid tumors to Bcl-xl inhibition.	USP9X BCL2L1	6.61e-05	3	164	2	23171055
Pubmed	Expression Profile of BCL-2, BCL-XL, and MCL-1 Predicts Pharmacological Response to the BCL-2 Selective Antagonist Venetoclax in Multiple Myeloma Models.	BCL2 BCL2L1	6.61e-05	3	164	2	26939706
Pubmed	Identifying the association between single nucleotide polymorphisms in KCNQ1, ARAP1, and KCNJ11 and type 2 diabetes mellitus in a Chinese population.	KCNJ11 ARAP1	6.61e-05	3	164	2	32922204
Pubmed	AdHu5-apoptin induces G2/M arrest and apoptosis in p53-mutated human gastric cancer SGC-7901 cells.	BCL2 BCL2L1	6.61e-05	3	164	2	23812727
Pubmed	Apoptosis and expression of Bcl-2, Bcl-XL, and Bax in renal cell carcinomas.	BCL2 BCL2L1	6.61e-05	3	164	2	12025227
Pubmed	Lewis y enhances CAM-DR in ovarian cancer cells by activating the FAK signaling pathway and upregulating Bcl-2/Bcl-XL expression.	BCL2 BCL2L1	6.61e-05	3	164	2	25726913
Pubmed	Bim escapes displacement by BH3-mimetic anti-cancer drugs by double-bolt locking both Bcl-XL and Bcl-2.	BCL2 BCL2L1	6.61e-05	3	164	2	30860026
Pubmed	Effect of bax, bcl-2 and bcl-xL on regulating apoptosis in tissues of normal liver and hepatocellular carcinoma.	BCL2 BCL2L1	6.61e-05	3	164	2	12439925
Pubmed	Role of phospholipase D2 in anti-apoptotic signaling through increased expressions of Bcl-2 and Bcl-xL.	BCL2 BCL2L1	6.61e-05	3	164	2	17541981
Pubmed	Physical and functional interactions between mitotic kinases during polyploidization and megakaryocytic differentiation.	AURKA PLK3	6.61e-05	3	164	2	15190214
Pubmed	Praf2 is a novel Bcl-xL/Bcl-2 interacting protein with the ability to modulate survival of cancer cells.	BCL2 BCL2L1	6.61e-05	3	164	2	21203533
Pubmed	p53 has a direct apoptogenic role at the mitochondria.	BCL2 BCL2L1	6.61e-05	3	164	2	12667443
Pubmed	Mcl-1, Bcl-XL and Stat3 expression are associated with progression of melanoma whereas Bcl-2, AP-2 and MITF levels decrease during progression of melanoma.	BCL2 BCL2L1	6.61e-05	3	164	2	17384650
Pubmed	Different expression patterns of Bcl-2, Bcl-xl, and Bax proteins after sublethal forebrain ischemia in C57Black/Crj6 mouse striatum.	BCL2 BCL2L1	6.61e-05	3	164	2	12791942
Pubmed	Identification of three novel non-classical cadherin genes through comprehensive analysis of large cDNAs.	CDH23 DCHS1	6.61e-05	3	164	2	11597768
Pubmed	PUMA induces the rapid apoptosis of colorectal cancer cells.	BCL2 BCL2L1	6.61e-05	3	164	2	11463391
Pubmed	PUMA, a novel proapoptotic gene, is induced by p53.	BCL2 BCL2L1	6.61e-05	3	164	2	11463392
Pubmed	Genome-wide profiling of methylation identifies novel targets with aberrant hypermethylation and reduced expression in low-risk myelodysplastic syndromes.	BCL2 IL27RA	6.61e-05	3	164	2	22936014
Pubmed	Mapping the BH3 Binding Interface of Bcl-xL, Bcl-2, and Mcl-1 Using Split-Luciferase Reassembly.	BCL2 BCL2L1	6.61e-05	3	164	2	25844633
Pubmed	Precursor IGF-II (proIGF-II) and mature IGF-II (mIGF-II) induce Bcl-2 And Bcl-X L expression through different signaling pathways in breast cancer cells.	BCL2 BCL2L1	6.61e-05	3	164	2	18428028
Pubmed	Eya2 Is Overexpressed in Human Prostate Cancer and Regulates Docetaxel Sensitivity and Mitochondrial Membrane Potential through AKT/Bcl-2 Signaling.	BCL2 EYA2	6.61e-05	3	164	2	31317026
Pubmed	Bcl-G, a novel pro-apoptotic member of the Bcl-2 family.	BCL2 BCL2L1	6.61e-05	3	164	2	11054413
Pubmed	High-resolution analysis of the conformational transition of pro-apoptotic Bak at the lipid membrane.	BCL2 BCL2L1	6.61e-05	3	164	2	34523144
Pubmed	A natural BH3 mimetic induces autophagy in apoptosis-resistant prostate cancer via modulating Bcl-2-Beclin1 interaction at endoplasmic reticulum.	BCL2 BCL2L1	6.61e-05	3	164	2	20577262
Pubmed	Transmembrane E3 ligase RNF183 mediates ER stress-induced apoptosis by degrading Bcl-xL.	BCL2 BCL2L1	6.61e-05	3	164	2	29507230
Pubmed	Paradoxical inhibition of c-myc-induced carcinogenesis by Bcl-2 in transgenic mice.	BCL2 BCL2L1	6.61e-05	3	164	2	10519417
Pubmed	Granulocyte macrophage-colony stimulating factor shows anti-apoptotic activity in neural progenitor cells via JAK/STAT5-Bcl-2 pathway.	BCL2 BCL2L1	6.61e-05	3	164	2	21052840
Pubmed	Tumor necrosis factor attenuates prion protein-deficient neuronal cell death by increases in anti-apoptotic Bcl-2 family proteins.	BCL2 BCL2L1	6.61e-05	3	164	2	14550262
Pubmed	Localization of bcl-2, bax, and bcl-x mRNAs in the developing inner ear of the mouse.	BCL2 BCL2L1	6.61e-05	3	164	2	8836552
Pubmed	Overexpression of Bcl-2 or Bcl-XL transgenes and photoreceptor degeneration.	BCL2 BCL2L1	6.61e-05	3	164	2	8933760
Pubmed	The Siva-1 putative amphipathic helical region (SAH) is sufficient to bind to BCL-XL and sensitize cells to UV radiation induced apoptosis.	BCL2 BCL2L1	6.61e-05	3	164	2	14739602
Pubmed	BH3 domain of BAD is required for heterodimerization with BCL-XL and pro-apoptotic activity.	BCL2 BCL2L1	6.61e-05	3	164	2	9305851
Pubmed	Novel BNIP1 variants and their interaction with BCL2 family members.	BCL2 BCL2L1	6.61e-05	3	164	2	10217402
Pubmed	Antisense strategy shows that Mcl-1 rather than Bcl-2 or Bcl-x(L) is an essential survival protein of human myeloma cells.	BCL2 BCL2L1	6.61e-05	3	164	2	12070027
Pubmed	Differential dependence on Beclin 1 for the regulation of pro-survival autophagy by Bcl-2 and Bcl-xL in HCT116 colorectal cancer cells.	BCL2 BCL2L1	6.61e-05	3	164	2	20090905
Pubmed	Simultaneous siRNA-mediated knockdown of antiapoptotic BCL2, Bcl-xL, XIAP and survivin in bladder cancer cells.	BCL2 BCL2L1	6.61e-05	3	164	2	22797576
Pubmed	The apoptotic members CD95, BclxL, and Bcl-2 cooperate to promote cell migration by inducing Ca(2+) flux from the endoplasmic reticulum to mitochondria.	BCL2 BCL2L1	6.61e-05	3	164	2	27367565
Pubmed	EGL-1 BH3 mutants reveal the importance of protein levels and target affinity for cell-killing potency.	BCL2 BCL2L1	6.61e-05	3	164	2	18566606
Pubmed	The cell death-promoting gene DP5, which interacts with the BCL2 family, is induced during neuronal apoptosis following exposure to amyloid beta protein.	BCL2 BCL2L1	6.61e-05	3	164	2	10075695
Pubmed	The role of apoptosis in the development of AGM hematopoietic stem cells revealed by Bcl-2 overexpression.	BCL2 BCL2L1	6.61e-05	3	164	2	14962910
Pubmed	Critical role of anti-apoptotic Bcl-2 protein phosphorylation in mitotic death.	BCL2 BCL2L1	6.61e-05	3	164	2	24091677
Pubmed	Noxa, a BH3-only member of the Bcl-2 family and candidate mediator of p53-induced apoptosis.	BCL2 BCL2L1	6.61e-05	3	164	2	10807576
Pubmed	The intracellular distribution and pattern of expression of Mcl-1 overlap with, but are not identical to, those of Bcl-2.	BCL2 HSPA9	6.61e-05	3	164	2	7896880
Pubmed	The rho-guanine nucleotide exchange factor domain of obscurin regulates assembly of titin at the Z-disk through interactions with Ran binding protein 9.	OBSCN RANBP9	6.61e-05	3	164	2	18579686
Pubmed	Anti-apoptotic proteins and catalase-dependent apoptosis resistance in nickel chloride-transformed human lung epithelial cells.	BCL2 BCL2L1	6.61e-05	3	164	2	23828460
Pubmed	The proapoptotic molecule BLID interacts with Bcl-XL and its downregulation in breast cancer correlates with poor disease-free and overall survival.	BCL2 BCL2L1	6.61e-05	3	164	2	20400521
Pubmed	Elevated expression of Bcl-2 and Bcl-x by intestinal intraepithelial lymphocytes: resistance to apoptosis by glucocorticoids and irradiation.	BCL2 BCL2L1	6.61e-05	3	164	2	9237103
Pubmed	Targeting Bcl-2 family proteins in adult T-cell leukemia/lymphoma: in vitro and in vivo effects of the novel Bcl-2 family inhibitor ABT-737.	BCL2 BCL2L1	6.61e-05	3	164	2	22138435
Interaction	TSPY8 interactions	TSPY3 TSPY2 TSPY8	4.64e-07	3	157	3	int:TSPY8
Cytoband	Yp11.2	TSPY4 TSPY3 TSPY2 TSPY9 TSPY8 TSPY1 TSPY10	5.15e-08	94	164	7	Yp11.2
Cytoband	Ensembl 112 genes in cytogenetic band chrYp11	TSPY4 TSPY3 TSPY2 TSPY9 TSPY8 TSPY1 TSPY10	1.25e-06	150	164	7	chrYp11
Cytoband	19p13.11	REX1BD NWD1 SLC27A1 IL27RA	1.41e-04	73	164	4	19p13.11
Cytoband	17q11	VTN SARM1	9.64e-04	13	164	2	17q11
Cytoband	Xp11.22	CENPVL2 CENPVL3 CENPVL1	9.71e-04	54	164	3	Xp11.22
Cytoband	5q23.3	SLC22A5 CHSY3	1.12e-03	14	164	2	5q23.3
GeneFamily	Cadherin related	DCHS2 CDH23 DCHS1	1.12e-04	17	102	3	24
GeneFamily	Netrins	NTN3 NTN5	4.66e-04	6	102	2	661
CoexpressionAtlas	DevelopingLowerUrinaryTract_P1_ureter_emap-30363_k-means-cluster#1_top-relative-expression-ranked_1000	DDX60 SLC52A3 PLA2R1 KBTBD11 C1R KAZALD1 ATP13A3 TNXB	3.47e-06	121	158	8	gudmap_developingLowerUrinaryTract_P1_ureter_1000_k1
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	GALNTL6 STAB2 ZAN OBSCN SORCS1 MELTF NRXN1 PKHD1	4.26e-07	184	164	8	2cbed6462fea2622871bb7e49b0df3d984239281
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	GALNTL6 STAB2 ZAN OBSCN SORCS1 MELTF NRXN1 PKHD1	4.26e-07	184	164	8	ea7a7e2bac46d4d2c31a5d576b38a032b5335062
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	GALNTL6 STAB2 ZAN OBSCN SORCS1 MELTF NRXN1 PKHD1	4.26e-07	184	164	8	2b19a8c5f823e00812908b23e66bb4e563278aff
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Degenerative_Descending_Thin_Limb_Cell_Type_3\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	BCL2 ARSH GDF7 PKHD1 ECEL1 CTDSPL PDZD2	2.59e-06	164	164	7	1cb5fbd7050650047ad6f2ca792118e98d58d22b
Disease	hematopoietic progenitor cell antigen CD34 measurement	VTN SARM1 CENPP	1.31e-07	3	151	3	EFO_0801667
Disease	clusterin measurement	VTN SARM1 C1R	4.53e-06	7	151	3	EFO_0007655
Disease	complement factor H-related protein 1 measurement	GALNTL6 VTN SARM1 CENPVL2 CENPVL3	1.02e-05	56	151	5	EFO_0600054
Disease	interleukin-36 alpha measurement	VTN SARM1 TNXB	1.08e-05	9	151	3	EFO_0021851
Disease	level of ubiquitin-conjugating enzyme E2 D2 in blood serum	VTN SARM1	2.60e-05	2	151	2	OBA_2043992
Disease	level of 2-phosphoxylose phosphatase 1 in blood serum	VTN SARM1	2.60e-05	2	151	2	OBA_2040484
Disease	level of ubiquitin-conjugating enzyme E2 G1 in blood serum	VTN SARM1	2.60e-05	2	151	2	OBA_2043995
Disease	level of acetyl-coenzyme A thioesterase in blood serum	VTN SARM1	2.60e-05	2	151	2	OBA_2040480
Disease	level of dynamin-1-like protein in blood serum	VTN SARM1	2.60e-05	2	151	2	OBA_2041335
Disease	level of uridine diphosphate glucose pyrophosphatase NUDT14 in blood serum	VTN SARM1	2.60e-05	2	151	2	OBA_2042666
Disease	level of NAD-dependent protein deacetylase sirtuin-1 in blood serum	VTN SARM1	2.60e-05	2	151	2	OBA_2043513
Disease	level of acetyl-coenzyme A synthetase, cytoplasmic in blood serum	VTN SARM1	2.60e-05	2	151	2	OBA_2040488
Disease	level of S-phase kinase-associated protein 2 in blood serum	VTN SARM1	2.60e-05	2	151	2	OBA_2043520
Disease	level of solute carrier family 22 member 16 in blood serum	VTN SARM1	2.60e-05	2	151	2	OBA_2043527
Disease	level of clustered mitochondria protein homolog in blood serum	VTN SARM1	2.60e-05	2	151	2	OBA_2044820
Disease	level of tRNA wybutosine-synthesizing protein 3 in blood serum	VTN SARM1	2.60e-05	2	151	2	OBA_2043977
Disease	level of dermokine in blood serum	VTN SARM1	2.60e-05	2	151	2	OBA_2041322
Disease	level of meiotic recombination protein DMC1/LIM15 in blood serum	VTN SARM1	2.60e-05	2	151	2	OBA_2041321
Disease	level of protein shisa-2 in blood serum	VTN SARM1	2.60e-05	2	151	2	OBA_2043501
Disease	level of uncharacterized protein C5orf46 in blood serum	VTN SARM1	2.60e-05	2	151	2	OBA_2044834
Disease	zinc finger protein 566 measurement	VTN SARM1	2.60e-05	2	151	2	EFO_0803282
Disease	level of interferon lambda-4 (human) in blood serum	VTN SARM1	2.60e-05	2	151	2	OBA_2044894
Disease	level of zinc finger CCHC domain-containing protein 18 (human) in blood serum	VTN SARM1	2.60e-05	2	151	2	OBA_2044897
Disease	zona pellucida-like domain-containing protein 1 measurement	VTN SARM1	2.60e-05	2	151	2	EFO_0803290
Disease	level of cilia- and flagella-associated protein 300 in blood serum	VTN SARM1	2.60e-05	2	151	2	OBA_2044864
Disease	level of diphthine methyl ester synthase in blood serum	VTN SARM1	2.60e-05	2	151	2	OBA_2041351
Disease	level of LIM domain kinase 1 in blood serum	VTN SARM1	2.60e-05	2	151	2	OBA_2042203
Disease	level of teneurin-4 in blood serum	VTN SARM1	2.60e-05	2	151	2	OBA_2042694
Disease	level of centriolar satellite-associated tubulin polyglutamylase complex regulator 1 in blood serum	VTN SARM1	2.60e-05	2	151	2	OBA_2044874
Disease	level of LIM domain transcription factor LMO4 in blood serum	VTN SARM1	2.60e-05	2	151	2	OBA_2042213
Disease	level of desmocollin-1 in blood serum	VTN SARM1	2.60e-05	2	151	2	OBA_2041365
Disease	urotensin-2 receptor measurement	VTN SARM1	2.60e-05	2	151	2	EFO_0803242
Disease	vesicle-associated membrane protein 3 measurement	VTN SARM1	2.60e-05	2	151	2	EFO_0803251
Disease	uromodulin-like 1 measurement	VTN SARM1	2.60e-05	2	151	2	EFO_0803239
Disease	uridine-cytidine kinase 2 measurement	VTN SARM1	2.60e-05	2	151	2	EFO_0803238
Disease	level of 4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase 9 in blood serum	VTN SARM1	2.60e-05	2	151	2	OBA_2044485
Disease	level of Ras-related protein Rab-43 in blood serum	VTN SARM1	2.60e-05	2	151	2	OBA_2043163
Disease	bromodomain testis-specific protein measurement	VTN SARM1	2.60e-05	2	151	2	EFO_0802339
Disease	level of dual specificity mitogen-activated protein kinase kinase 5 in blood serum	VTN SARM1	2.60e-05	2	151	2	OBA_2042285
Disease	level of adhesion G-protein coupled receptor F1 in blood serum	VTN SARM1	2.60e-05	2	151	2	OBA_2044476
Disease	level of purine nucleoside phosphorylase LACC1 in blood serum	VTN SARM1	2.60e-05	2	151	2	OBA_2044472
Disease	level of Ras-related protein Rab-17 in blood serum	VTN SARM1	2.60e-05	2	151	2	OBA_2043141
Disease	COP9 signalosome complex subunit 2 measurement	VTN SARM1	2.60e-05	2	151	2	EFO_0801497
Disease	cubilin measurement	VTN SARM1	2.60e-05	2	151	2	EFO_0802433
Disease	level of G2/mitotic-specific cyclin-B2 in blood serum	VTN SARM1	2.60e-05	2	151	2	OBA_2040934
Disease	level of ubiquitin carboxyl-terminal hydrolase 30 in blood serum	VTN SARM1	2.60e-05	2	151	2	OBA_2044064
Disease	level of UDP-glucuronosyltransferase 2A1 in blood serum	VTN SARM1	2.60e-05	2	151	2	OBA_2044026
Disease	level of beta-ureidopropionase in blood serum	VTN SARM1	2.60e-05	2	151	2	OBA_2044041
Disease	level of transcription initiation factor IIA subunit 2 in blood serum	VTN SARM1	2.60e-05	2	151	2	OBA_2041812
Disease	level of general transcription factor IIE subunit 1 in blood serum	VTN SARM1	2.60e-05	2	151	2	OBA_2041814
Disease	level of variable charge X-linked protein 1 in blood serum	VTN SARM1	2.60e-05	2	151	2	OBA_2044092
Disease	CMRF35-like molecule 1 measurement	VTN SARM1	2.60e-05	2	151	2	EFO_0802405
Disease	level of urotensin-2 in blood serum	VTN SARM1	2.60e-05	2	151	2	OBA_2044071
Disease	cortexin-3 measurement	VTN SARM1	2.60e-05	2	151	2	EFO_0801500
Disease	level of ADP-ribosylhydrolase ARH1 in blood serum	VTN SARM1	2.60e-05	2	151	2	OBA_2040524
Disease	level of acireductone dioxygenase in blood serum	VTN SARM1	2.60e-05	2	151	2	OBA_2040520
Disease	level of protein LTO1 homolog in blood serum	VTN SARM1	2.60e-05	2	151	2	OBA_2042709
Disease	pappalysin-2 measurement	VTN SARM1	2.60e-05	2	151	2	EFO_0802846
Disease	receptor-type tyrosine-protein phosphatase H measurement	VTN SARM1	2.60e-05	2	151	2	EFO_0801991
Disease	orphan sodium- and chloride-dependent neurotransmitter transporter NTT5 measurement	VTN SARM1	2.60e-05	2	151	2	EFO_0802836
Disease	level of 2-hydroxyacyl-CoA lyase 1 in blood serum	VTN SARM1	2.60e-05	2	151	2	OBA_2041832
Disease	tropomyosin alpha-1 chain measurement	VTN SARM1	2.60e-05	2	151	2	EFO_0020786
Disease	level of centrin-2 in blood serum	VTN SARM1	2.60e-05	2	151	2	OBA_2040991
Disease	protocadherin gamma-C5 measurement	VTN SARM1	2.60e-05	2	151	2	EFO_0801977
Disease	tryptase gamma measurement	VTN SARM1	2.60e-05	2	151	2	EFO_0020792
Disease	level of endothelin-3 in blood serum	VTN SARM1	2.60e-05	2	151	2	OBA_2041415
Disease	level of jupiter microtubule associated homolog 1 in blood serum	VTN SARM1	2.60e-05	2	151	2	OBA_2041898
Disease	level of elongation factor 1-gamma in blood serum	VTN SARM1	2.60e-05	2	151	2	OBA_2041421
Disease	level of palmdelphin in blood serum	VTN SARM1	2.60e-05	2	151	2	OBA_2042753
Disease	level of TPT1-like protein (human) in blood serum	VTN SARM1	2.60e-05	2	151	2	OBA_2044904
Disease	e3 ubiquitin-protein ligase mdm2 measurement	VTN SARM1	2.60e-05	2	151	2	EFO_0020340
Disease	level of uncharacterized protein C2orf66 (human) in blood serum	VTN SARM1	2.60e-05	2	151	2	OBA_2044907
Disease	level of MHC class I histocompatibility antigen, alpha chain E in blood serum	VTN SARM1	2.60e-05	2	151	2	OBA_2041881
Disease	level of small integral membrane protein 10 (human) in blood serum	VTN SARM1	2.60e-05	2	151	2	OBA_2044919
Disease	level of transmembrane protease serine 6 in blood serum	VTN SARM1	2.60e-05	2	151	2	OBA_2043885
Disease	level of protein FAM210A in blood serum	VTN SARM1	2.60e-05	2	151	2	OBA_2044718
Disease	level of kinesin-like protein KIF3C in blood serum	VTN SARM1	2.60e-05	2	151	2	OBA_2042101
Disease	level of kinesin light chain 1 in blood serum	VTN SARM1	2.60e-05	2	151	2	OBA_2042116
Disease	14-3-3 protein theta measurement	VTN SARM1	2.60e-05	2	151	2	EFO_0022011
Disease	level of succinate dehydrogenase [ubiquinone] iron-sulfur subunit, mitochondrial in blood serum	VTN SARM1	2.60e-05	2	151	2	OBA_2043415
Disease	level of signal transducer and activator of transcription 5a in blood serum	VTN SARM1	2.60e-05	2	151	2	OBA_2040390
Disease	level of probable E3 ubiquitin-protein ligase HERC4 in blood serum	VTN SARM1	2.60e-05	2	151	2	OBA_2044752
Disease	level of translation machinery-associated protein 16 in blood serum	VTN SARM1	2.60e-05	2	151	2	OBA_2044750
Disease	level of acyl-CoA-binding domain-containing protein 7 in blood serum	VTN SARM1	2.60e-05	2	151	2	OBA_2044758
Disease	t-box transcription factor TBX5 measurement	VTN SARM1	2.60e-05	2	151	2	EFO_0803129
Disease	level of NmrA-like family domain-containing protein 1 in blood serum	VTN SARM1	2.60e-05	2	151	2	OBA_2044335
Disease	SPRY domain-containing SOCS box protein 1 measurement	VTN SARM1	2.60e-05	2	151	2	EFO_0803103
Disease	level of kallikrein-6 in blood serum	VTN SARM1	2.60e-05	2	151	2	OBA_2042128
Disease	level of arginine-hydroxylase NDUFAF5, mitochondrial in blood serum	VTN SARM1	2.60e-05	2	151	2	OBA_2044792
Disease	level of SET-binding protein in blood serum	VTN SARM1	2.60e-05	2	151	2	OBA_2043468
Disease	level of keratin, type I cytoskeletal 14 in blood serum	VTN SARM1	2.60e-05	2	151	2	OBA_2042138
Disease	level of interferon-inducible double-stranded RNA-dependent protein kinase activator A in blood serum	VTN SARM1	2.60e-05	2	151	2	OBA_2043031
Disease	level of lengsin in blood serum	VTN SARM1	2.60e-05	2	151	2	OBA_2042191
Disease	level of transmembrane protein 87B in blood serum	VTN SARM1	2.60e-05	2	151	2	OBA_2044370
Disease	level of multifunctional methyltransferase subunit TRM112-like protein in blood serum	VTN SARM1	2.60e-05	2	151	2	OBA_2044371
Disease	level of WD repeat-containing protein 18 in blood serum	VTN SARM1	2.60e-05	2	151	2	OBA_2044380
Disease	level of melanoma antigen preferentially expressed in tumors in blood serum	VTN SARM1	2.60e-05	2	151	2	OBA_2043016
Disease	level of GTPase HRas in blood serum	VTN SARM1	2.60e-05	2	151	2	OBA_2044350
Disease	level of solute carrier family 35 member G2 in blood serum	VTN SARM1	2.60e-05	2	151	2	OBA_2044355
Disease	WD repeat-containing protein 1 measurement	VTN SARM1	2.60e-05	2	151	2	EFO_0802221

Protein segments in the cluster

Peptide	Gene	Start	Entry
DWRGQPFLREEVARF	ACCSL	206	Q4AC99
RQREPAAAAVALGRW	C1orf167	526	Q5SNV9
GIFRWPSVLEAGRVI	ARSH	361	Q5FYA8
AFRAVDNDPGIIVWR	AVIL	6	O75366
RQWALEDFEIGRPLG	AURKA	126	O14965
PWELVIRAAVAGFFA	CTAGE1	11	Q96RT6
VAWRRNDPGAKFTII	B4GALNT3	261	Q6L9W6
WGIQRVENARFLSPE	ATP13A3	511	Q9H7F0
GNEEWFLVGRVLDRV	CHRNG	461	P07510
FWVERTPVHEAAQRG	ASB13	16	Q8WXK3
SPGRVAAEWEVQNRI	ACAD10	56	Q6JQN1
TWARALRFADGPDEV	ACAD10	1031	Q6JQN1
VVNELFRDGVNWGRI	BCL2L1	126	Q07817
NGDEAVREFWRLLAI	ATP8B3	556	O60423
AVRFAVWAPADLRVV	CENPVL1	141	A0A0U1RR11
GVLDFNADRLRGVDW	CEP78	41	Q5JTW2
VGRVPVDDVWFALDT	LVRN	171	Q6Q4G3
FREQVDQGPDWERGF	BMP4	161	P12644
GVFAVRDPNTDRWVA	C1R	656	P00736
RFFAVEPDTGVVWLR	CDH23	76	Q9H251
AGNRDWEFFIIDPIS	CDH23	2656	Q9H251
ASRPGFELVIVWRIQ	CENPP	211	Q6IPU0
WGPLQEDADIQVYRR	ADAMTS13	646	Q76LX8
LGDRQFQSPLRWEVV	ABCA7	1716	Q8IZY2
VADFIGLDPRIAAWL	POLN	341	Q7Z5Q5
AARINLPEARVQIWF	ISX	116	Q2M1V0
FEVVDLRWGIRNIEA	NWD1	26	Q149M9
AQIDRFPIGDREGEW	RANBP9	351	Q96S59
LRERFSPFGDIQDIW	RBM45	41	Q8IUH3
IREPLGLRVWQFVSA	TP53I11	56	O14683
RRALEAFDLDPAQWG	SHMT2	121	P34897
IVDDVWVVRPLFGRR	ACP7	421	Q6ZNF0
YRRPVAERAQDIGIW	ANO7	751	Q6IWH7
WVFQDRQLEGGARPL	MMP25	391	Q9NPA2
NWGRVFQLEPRLAEA	DCHS1	2526	Q96JQ0
RLQIRPADGDVAAQW	DTD2	21	Q96FN9
LWVQAAAPGDRIRFQ	LDLRAD2	66	Q5SZI1
SRVDEVWPNLFIGDA	DUSP13	36	Q6B8I1
RFEVTGWLQIQAVRP	KAZALD1	231	Q96I82
VIFLNGNRAPEEAVW	MAGEB18	206	Q96M61
QAAAEFDGRWPRQIV	NPNT	16	Q6UXI9
LSVEERGPSWVRFVF	NUDT18	106	Q6ZVK8
LRAFGWARVALVTAP	GUCY2D	176	Q02846
QVFTFTWREDIRPGD	GALNT10	501	Q86SR1
AEKWFPGQRERARAA	LONRF1	201	Q17RB8
VFVARGALWGAEDIR	ASPDH	121	A6ND91
RRVAWARIPAQDVLF	FER1L4	671	A9Z1Z3
CPVLREFRVEVLFWG	FER1L4	931	A9Z1Z3
VSVWRRSGPFALEEA	FER1L4	1566	A9Z1Z3
EQIAVPRNDEWARFG	DYNC1I2	601	Q13409
QVWPEGSDIRRVFCV	DDX60	251	Q8IY21
RGAASRFVKNALWEP	C1D	111	Q13901
ADEILWGQRFVPIVA	KCNJ11	306	Q14654
WGQRFVPIVAEEDGR	KCNJ11	311	Q14654
RAVGWNELEGRDAIF	PCBD1	21	P61457
ATLPVAVWFGATERR	PLXNB1	1226	O43157
VEAFDPVLNRWELVG	KLHL8	571	Q9P2G9
GEAAQDLPFRRSWSV	PDZD2	2561	O15018
VAVAAGRSWVAIPRE	IL27RA	81	Q6UWB1
GPGAEDVAVWTRAQR	MEGF8	736	Q7Z7M0
ETLQARREWGPIFNI	L1RE1	256	Q9UN81
EEARRQGLPFAQWDG	PPFIA1	866	Q13136
IRVDNVRPRWDFTGA	KCNK13	86	Q9HB14
EREPFKGWIRDVRVN	NRXN1	176	Q9ULB1
FRVVVVDSRPWLEGR	EIF2B4	356	Q9UI10
PFKIVRASNGDAWVE	HSPA9	141	P38646
FRVAWTEKNDGQRAP	GPR83	381	Q9NYM4
AEERPGVAARWDLNR	ECEL1	216	O95672
VVRAFRWEELGEGPE	ITFG2	151	Q969R8
FQPLASREVDGWRQL	HPDL	31	Q96IR7
FAVEELSGVVRVWRP	DCHS2	356	Q6V1P9
LRGWEAFLNAPEANR	HTATSF1	366	O43719
DVAVVWFRDGALLQP	OBSCN	1926	Q5VST9
ARGAWTRFPVAVLAV	NTN3	476	O00634
AWLADELFGPDRAII	OOEP	56	A6NGQ2
RPLWEQVQGFREAVV	PPT2	81	Q9UMR5
QGDPGIFAWEIRDRL	PAX1	186	P15863
QARVEELERWVYGPG	DCTN3	11	O75935
LGEFEADPRGQLWQR	CMPK2	161	Q5EBM0
AVRFAVWAPADLRVV	CENPVL2	141	P0DPI3
DPVADLLDRWGVFRA	CTDSPL	176	O15194
ARWPRKLQVDGVFVT	FCGBP	3346	Q9Y6R7
SARWPRKLQVDGVFV	FCGBP	4546	Q9Y6R7
AVRFAVWAPADLRVV	CENPVL3	141	A0A0U1RRI6
WIRARVEVKATFGPA	DDX12P	896	Q92771
PAFTVLGEAWRDQVD	CSAG2	41	Q9Y5P2
FLQGVFQEDPEWRAL	ERAP2	566	Q6P179
AIARRPKGQQLAWDF	ERAP2	861	Q6P179
LRQPQAWKDRFIDGF	LCAT	216	P04180
QWVVFDFGRRPVLLQ	HELZ2	251	Q9BYK8
FAERQAVRETWGSPA	B3GNT8	161	Q7Z7M8
QGFLDKPGRADEQWR	CACNA1H	2141	O95180
REGWTVQDVARVLGF	PNMA1	111	Q8ND90
PRWLISQGRFEEAEV	SLC22A5	281	O76082
ELPWSADRAIQQFGR	SBNO1	966	A3KN83
WRGELVAVKAARQDP	MAP3K11	136	Q16584
AAATRGLPAARVRWE	NDUFB11	16	Q9NX14
SVRARFVRFVPLEWN	CNTNAP5	146	Q8WYK1
PRGIWEAEVTRAFGA	NYNRIN	151	Q9P2P1
HVFARWGVPVRLEAA	NYNRIN	1666	Q9P2P1
VFAPDRESRQRWVLA	ITK	91	Q08881
DVWAVLDQFGRSRPI	MROH5	341	Q6ZUA9
PAGDNEIERVFVWDL	EYA2	261	O00167
QLFTFGWREDIRPGE	GALNTL6	496	Q49A17
EAVRWAPVGAVAEAR	RUNDC1	36	Q96C34
WVVRGVFALALRATP	PLEKHA8P1	331	O95397
QLVATGAVRDWDDPR	QARS1	501	P47897
RFPNQGRQVDDLEVW	USP9X	891	Q93008
RFIQRPGDLVWINAG	UTY	1156	O14607
AGNEWRRPIIQFVES	TRIM29	71	Q14134
VSAQWVAEALRAPRA	MPST	11	P25325
VAFFVLQRQPRCWEA	SLC52A3	236	Q9NQ40
DAPRWDQRTFLGRVK	SFXN2	11	Q96NB2
WDVPVGALIQRGFIR	MELTF	486	P08582
AWPRRDGADGFVQLD	SPATA5L1	61	Q9BVQ7
AEAPAAGIRFRRWAT	SYNM	1056	O15061
ASEAAGPAWQRLAVR	NTN5	376	Q8WTR8
APEGRARLWDVFRDN	NKPD1	461	Q17RQ9
DVVDRERFCRWAGLP	MOV10	756	Q9HCE1
DIDWPIAEQRVLRYG	CMAS	251	Q8NFW8
QARRLDGIDYNPWVE	KYAT1	6	Q16773
EPLVGQRWEAFDVAD	GDF7	201	Q7Z4P5
WRNGPVEERLEYALV	MTR	666	Q99707
WLRYQGVPVEEDVGR	SLC38A7	351	Q9NVC3
ELPWSADRAIQQFGR	SBNO2	826	Q9Y2G9
AKRFGQAAWATAIPR	WHAMM	321	Q8TF30
FSRDPALVWVLVGNR	PKHD1	1221	P08F94
PAAVEVWAGNRFFAR	PKHD1	1266	P08F94
WEPATLRRVFVVGVG	SCP2	6	P22307
PRVVERQWEAGSAGA	KBTBD11	71	O94819
VQGDWIRERRFEIPD	OCRL	86	Q01968
RANDEFRWRDGTPVI	PLA2R1	881	Q13018
ERWYLAAQVAVARGP	STARD3	181	Q14849
GVPGRWAFRIDDAQV	SNED1	246	Q8TER0
VRDPQRSFALGIQWI	SLCO4A1	606	Q96BD0
ELFRDGVNWGRIVAF	BCL2	136	P10415
EVAERIWAAAPNRFC	ARAP1	536	Q96P48
AQRTWARFIPGRVEF	CHSY3	191	Q70JA7
RGADWRVAHVEVAPF	XPR1	171	Q9UBH6
PLVQEDSRRLWFIVG	TMPRSS11D	371	O60235
LDRRGAVIQSVPGFW	TSPY9	151	A0A494C1R9
DRRGAVIQSVPGFWA	TSPY10	146	P0CW01
SGWEPLLVTFVARNR	PLK3	596	Q9H4B4
DRRGAVIQSVPGFWA	TSPY2	146	A6NKD2
LDRRGAVIQSVPGFW	TSPY4	151	P0CV99
FWPAVREDNRRVALA	YIPF1	246	Q9Y548
DRRGAVIQSVPGFWA	TSPY1	146	Q01534
FQLVEEAWLLPAVGR	SARM1	96	Q6SZW1
LRPAIWEEFTERFGV	SLC27A1	366	Q6PCB7
LRADVWETFQQRFGP	SLC27A5	411	Q9Y2P5
ERAQGFRRLEEWLAP	REX1BD	51	Q96EN9
AWERLVGEIAFQLDR	SPATC1	441	Q76KD6
VDAWPGQRERATAIL	SREBF2	1071	Q12772
VTGWERAITVFRPQN	WDR49	251	Q8IV35
LELGWLRPQAEVDRF	TNXB	856	P22105
WRIGDFRPNHVVEGT	KCNJ16	201	Q9NPI9
RADIFVQNLVPDWRG	SLC12A3	321	P55017
PTETRFVDGRAILQW	STAB2	2416	Q8WWQ8
AFPITLEWGGRVVRE	VCPIP1	591	Q96JH7
DPRWGAFAQSILERG	TOP3A	386	Q13472
DRRGAVIQSVPGFWA	TSPY3	146	P0CV98
DRRGAVIQSVPGFWA	TSPY8	146	P0CW00
RNDIIRNIPGFWVTA	TSPYL6	241	Q8N831
VRWFKEEQLPRRAGF	SH2D4B	301	Q5SQS7
ARAAVWEVDFPDVAR	LCMT2	106	O60294
VRPLFWSTNERGALV	ZNF589	151	Q86UQ0
QRAAFVRDVLLPGEW	SMARCA5	266	O60264
EFGRRWQLIQEGVVP	SORCS1	301	Q8WY21
IRDVWGIEGPIDAAF	VTN	196	P04004
RGDLAFRDDSIWPQE	TDGF1P3	41	P51864
VGRWDQDYDRAVLPL	TWF2	46	Q6IBS0
GAEVAQPREQRRVWF	ZFYVE9	816	O95405
RRVWFADGILPNGEV	ZFYVE9	826	O95405
AWDEDTAQIGPKRIR	ZNF692	306	Q9BU19
PERAGWTEALRAAVA	YRDC	61	Q86U90
TEFGLRVRWDGDQQL	ZAN	1261	Q9Y493
SVGEEGVFPRARWEL	FAM53A	376	Q6NSI3
GVFPRARWELDLEQI	FAM53A	381	Q6NSI3
DVAANRLWVTPGERE	KIAA2013	101	Q8IYS2